Insomnia Found to Be Common Among Nonhospitalized COVID-19 Survivors
By Lori Solomon HealthDay Reporter
TUESDAY, Feb. 13, 2024 -- There is a substantial burden of insomnia among nonhospitalized COVID-19 survivors, according to a study published online Feb. 4 in Frontiers in Public Health.
Huong Thi Xuan Hoang, Ph.D., from Phenikaa University in Hanoi, Vietnam, and colleagues assessed the prevalence of insomnia and identified its association with depression and anxiety among nonhospitalized participants who recovered from COVID-19. The analysis included 1,056 COVID-19 survivors evaluated within six months of initial COVID-19 infection.
The researchers found that the prevalence of insomnia was 76.1 percent, and among those with insomnia, 22.8 percent had severe insomnia. One-third of participants reported that after COVID-19 infection, sleep quality was worse, sleep duration was shorter, and falling asleep was harder, while half reported more awaken nights after COVID-19 infection. The risk for insomnia was more than tripled for participants with depressive (odds ratio, 3.45) or anxiety (odds ratio, 3.93) symptoms. Preexisting chronic conditions and higher education level were also risk factors for insomnia. There were no associations observed between insomnia and COVID-19 symptoms or duration.
"Since this is a cross-sectional study, the relationship of anxiety and depression with insomnia cannot be fully investigated," Hoang said in a statement. "In addition, collecting data online and a convenience sampling method can cause recall bias and selection bias. However, due to the situation in Vietnam at that time, collecting data via electronic invitation and convenience sampling was the most efficient and feasible strategy."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2024 HealthDay. All rights reserved.
Posted February 2024
Further Support and Information on COVID-19
Read this next
Active Surveillance Effective Strategy for Favorable-Risk Prostate Cancer
FRIDAY, May 31, 2024 -- Active surveillance is an effective management strategy for men with favorable-risk prostate cancer, with an estimated rate of metastasis of 1.4 percent at...
BMI Cutoff of 30 for Obesity May Be Too High for Middle-Aged, Older Adults
FRIDAY, May 31, 2024 -- The optimal body mass index (BMI) cutoff point appears to be 27 kg/m2 for detecting obesity in middle-aged and older adults, according to a study presented...
Emergency Inguinal Hernia Surgery Rates Increased With Lower Country Income
FRIDAY, May 31, 2024 -- For patients undergoing inguinal hernia surgery, emergency surgery rates increase from high- to low-income countries, according to a study published online...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.